United States: Yearly Stock Market Performance Insight - 2006

Yearly Gainers
1,456
Yearly Losers
564
Average Return
99.64%
Total Stocks
2,120
View Detailed Market Cap Breakdown
Market CapYearly GainersYearly LosersAverage ReturnTotal Stocks
Mega Cap 29 7 18.59% 37
Large Cap 388 94 20.25% 492
Mid Cap 345 121 23.54% 486
Small Cap 134 46 25.87% 190

Yearly Streak Leaders for 2006

Stock Streak Streak Return
6 years โ†‘ 64.54%

Procter & Gamble demonstrates exceptional long-term growth with a 6-year growth streak (39.06 โ†’ 64.27), delivering 64.5% cumulative returns. Annual financials validate this performance: 19.8B revenue generating 3.8B net profit (19.2% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

5 years โ†‘ 63.95%

Wells Fargo solidifies its market leadership with a 5-year growth streak (21.69 โ†’ 35.56), delivering 63.9% cumulative returns. With 20.1B annual revenue generating only 4.8B profit (23.8% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

3 years โ†“ -26.46%

Eli Lilly and encounters consecutive annual declines with a 3-year decline (70.85 โ†’ 52.10), down 26.5% cumulatively. Yet fundamentals remain solid: 12.7B annual revenue generating 2.8B profit (21.7% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

3 years โ†“ -13.44%

Walmart encounters consecutive annual declines with a 3-year decline (17.78 โ†’ 15.39), down 13.4% cumulatively. Weak margins on 165.6B annual revenue with only 4.6B profit (2.8% margin) in Qtr ending Apr 2025 validate market skepticism. Structural improvements needed before recovery.

13 years โ†‘ 4,208.51%

Expeditors demonstrates exceptional long-term growth with a 13-year growth streak (0.94 โ†’ 40.50), delivering 4,208.5% cumulative returns. With 2.7B annual revenue generating only 204.1M profit (7.7% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

11 years โ†‘ 4,204.40%

Pool continues its impressive multi-year expansion with a 11-year growth streak (0.91 โ†’ 39.17), delivering 4,204.4% cumulative returns. With 1.1B annual revenue generating only 53.5M profit (5.0% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

5 years โ†“ -82.25%

Tenet Healthcare endures extended market pressure with a 5-year decline (157.07 โ†’ 27.88), down 82.2% cumulatively. Weak margins on 5.2B annual revenue with only 622.0M profit (11.9% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

3 years โ†“ -70.57%

Insmed encounters consecutive annual declines with a 3-year decline (29.90 โ†’ 8.80), down 70.6% cumulatively. Financial struggles compound yearly losses: despite 92.8M annual revenue, - 256.6M losses persist (-276.4% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

10 years โ†‘ 2,765.09%

Oshkosh demonstrates exceptional long-term growth with a 10-year growth streak (1.69 โ†’ 48.42), delivering 2,765.1% cumulative returns. With 2.3B annual revenue generating only 112.2M profit (4.9% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

8 years โ†‘ 3,695.06%

Ssr Mining solidifies its market leadership with a 8-year growth streak (0.81 โ†’ 30.74), delivering 3,695.1% cumulative returns. Annual financials validate this performance: 316.6M revenue generating 54.4M net profit (17.2% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

3 years โ†“ -80.86%

Kratos Defense sees continued yearly losses with a 3-year decline (148.90 โ†’ 28.50), down 80.9% cumulatively. Weak margins on 302.6M annual revenue with only 4.5M profit (1.5% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

3 years โ†“ -72.44%

Sanmina navigates difficult years with a 3-year decline (75.12 โ†’ 20.70), down 72.4% cumulatively. Weak margins on 2.0B annual revenue with only 70.5M profit (3.6% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

7 years โ†‘ 1,297.14%

Pediatrix Medical solidifies its market leadership with a 7-year growth streak (1.75 โ†’ 24.45), delivering 1,297.1% cumulative returns. While annual revenue reaches 458.4M, net income of 20.7M (4.5% margin) in Qtr ending Mar 2025 shows the company prioritizes growth over margins - common for expanding Healthcare players.

7 years โ†‘ 951.43%

National Healthcare demonstrates exceptional long-term growth with a 7-year growth streak (5.25 โ†’ 55.20), delivering 951.4% cumulative returns. With 373.7M annual revenue generating only 32.3M profit (8.6% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

4 years โ†“ -50.91%

La-Z-Boy endures extended market pressure with a 4-year decline (24.18 โ†’ 11.87), down 50.9% cumulatively. Weak margins on 570.9M annual revenue with only 15.4M profit (2.7% margin) in Qtr ending Apr 2025 validate market skepticism. Structural improvements needed before recovery.

3 years โ†“ -51.09%

Celldex Therapeutics encounters consecutive annual declines with a 3-year decline (493.20 โ†’ 241.20), down 51.1% cumulatively. Financial struggles compound yearly losses: despite 695,000 annual revenue, - 53.8M losses persist (-7740.4% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

United States Market Yearly Gainers & Losers: 2006

Top United States Stock Gainers (2006)

StockYear OpenYear CloseYearly ChangeAvg Daily VolumeYear Volume
$0.31 $0.62 106.67% 611.34M 154.06B
$17.21 $27.33 59.64% 52.56M 13.25B
$18.50 $27.00 45.95% 24.35M 6.14B
$57.17 $81.43 43.51% 4.20M 1.06B
$23.75 $33.81 42.96% 10.56M 2.66B
$7.30 $21.58 196.84% 8.20M 2.07B
$7.12 $19.66 178.87% 1.98M 499.28M
$20.00 $53.12 166.53% 4.04M 1.02B
$36.40 $90.68 151.33% 2.98M 751.22M
$39.72 $89.48 126.70% 2.14M 539.14M
$0.62 $4.62 755.56% 119.36K 30.08M
$1.82 $8.05 342.31% 217.17K 54.73M
$2.11 $7.93 275.83% 451.87K 113.87M
$5.20 $18.74 272.56% 22.04K 5.55M
$2.00 $6.49 224.50% 1.21K 304.00K
$2.35 $7.75 236.96% 63.72K 16.06M
$6.25 $17.45 179.65% 229.56K 57.85M
$5.49 $14.83 175.65% 96.03K 24.20M
$2.35 $5.62 137.13% 65.55K 16.52M
$4.55 $10.19 132.65% 76.31K 19.23M

Biggest United States Stock Losers (2006)

StockYear OpenYear CloseYearly ChangeAvg Daily VolumeYear Volume
$31.02 $20.35 -33.50% 19.21M 4.84B
$2.37 $1.97 -16.53% 142.15M 35.82B
$62.60 $53.73 -13.53% 8.22M 2.07B
$57.19 $52.10 -7.93% 4.04M 1.02B
$3.87 $3.69 -4.65% 9.38M 2.36B
$63.35 $10.42 -83.39% 1.55M 389.55M
$19.80 $8.80 -54.17% 159.15K 40.10M
$33.66 $18.47 -44.37% 472.85K 119.16M
$6.60 $4.08 -37.04% 3.91K 984.51K
$3.75 $2.46 -34.05% 1.62M 409.00M
$3.65 $1.23 -66.30% 135.66K 34.19M
$30.04 $13.84 -54.11% 66.74K 16.82M
$18.50 $9.02 -51.27% 92.15K 23.22M
$2.48 $1.30 -47.58% 14.34K 3.61M
$68.10 $35.40 -47.16% 4.19M 1.06B
$7.18 $3.76 -46.74% 642.45K 161.90M
$1.68 $0.98 -41.67% 2.38K 598.50K
$3.39 $2.16 -37.57% 27.26K 6.87M
$22.71 $14.91 -34.52% 250.50K 63.13M
$18.57 $12.25 -33.68% 59.02K 14.87M

Most Active United States Stocks During 2006

StockYear OpenYear CloseYearly ChangeAvg Daily VolumeYearly Volume
$2.59 $3.03 17.90% 855.95M 215.70B
$0.31 $0.62 106.67% 611.34M 154.06B
$10.57 $11.52 10.98% 338.02M 85.18B
$2.37 $1.97 -16.53% 142.15M 35.82B
$26.25 $29.86 14.19% 66.80M 16.83B
$25.19 $20.25 -18.87% 70.62M 17.80B
$1.68 $2.81 71.34% 68.40M 17.24B
$18.40 $12.66 -30.40% 40.00M 10.08B
$2.83 $3.83 35.82% 37.39M 9.42B
$7.72 $7.51 -2.72% 33.63M 8.47B
$22.20 $42.59 93.59% 17.24M 4.34B
$4.40 $5.80 31.52% 16.35M 4.12B
$7.04 $9.26 31.35% 10.23M 2.58B
$10.83 $9.48 -11.73% 10.11M 2.55B
$4.65 $6.31 31.73% 7.32M 1.84B
$23.74 $15.91 -32.56% 6.77M 1.71B
$5.06 $7.47 47.92% 5.05M 1.27B
$14.72 $14.20 -7.67% 4.83M 1.22B
$15.52 $31.21 103.72% 4.19M 1.06B
$6.92 $10.67 55.99% 2.20M 554.07M

United States Sector Performance During 2006

Healthcare

423.57%
259 stocks
Top Performers by Market Cap:

Basic Materials

38.13%
123 stocks
Top Performers by Market Cap:
Mega Cap: LIN +12.03%
Large Cap: AEM +108.70%
Small Cap: MTRN +112.39%

Real Estate

28.50%
112 stocks
Top Performers by Market Cap:
Large Cap: EQIX +85.53%
Small Cap: ALX +70.94%

Communication Services

28.12%
71 stocks
Top Performers by Market Cap:
Mega Cap: T +45.95%
Large Cap: LYV +70.99%
Small Cap: LGF.A +39.71%

Industrials

25.09%
340 stocks
Top Performers by Market Cap:
Mega Cap: GE +6.17%
Large Cap: ATI +151.33%
Small Cap: GIC +179.65%

Consumer Defensive

21.89%
101 stocks
Top Performers by Market Cap:
Mega Cap: KO +19.64%
Large Cap: MNST +71.34%
Small Cap: ANDE +96.80%

Technology

19.61%
281 stocks
Top Performers by Market Cap:
Mega Cap: NVDA +106.67%
Large Cap: AKAM +166.53%
Mid Cap: BB +93.59%
Small Cap: CNXN +175.65%

Energy

19.12%
94 stocks
Top Performers by Market Cap:
Mega Cap: XOM +36.43%
Large Cap: OKE +61.92%
Small Cap: DNN +132.65%

Financial Services

18.63%
408 stocks
Top Performers by Market Cap:
Mega Cap: MS +43.51%
Large Cap: ICE +196.84%
Small Cap: WT +236.96%

Utilities

16.93%
61 stocks
Top Performers by Market Cap:
Large Cap: ES +43.02%
Mid Cap: OGE +49.25%
Small Cap: SJW +70.37%

Consumer Cyclical

16.70%
248 stocks
Top Performers by Market Cap:
Mega Cap: MCD +31.47%
Large Cap: LVS +126.70%
Small Cap: AEO +103.72%

Data is updated regularly. Yearly performance is calculated based on closing prices.